Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Treasury Shares (2017 - 2025)

Assembly Biosciences has reported Treasury Shares over the past 10 years, most recently at $85583.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $85583.0 for Q4 2025, up 440.57% from a year ago — trailing twelve months through Dec 2025 was $85583.0 (up 440.57% YoY), and the annual figure for FY2025 was $85583.0, up 440.57%.
  • Treasury Shares for Q4 2025 was $85583.0 at Assembly Biosciences, up from $15832.0 in the prior quarter.
  • Over the last five years, Treasury Shares for ASMB hit a ceiling of $1.8 million in Q3 2022 and a floor of $15832.0 in Q4 2024.
  • Median Treasury Shares over the past 5 years was $141544.0 (2022), compared with a mean of $649769.7.
  • Biggest five-year swings in Treasury Shares: crashed 94.96% in 2021 and later surged 3574.1% in 2022.
  • Assembly Biosciences' Treasury Shares stood at $970339.0 in 2021, then plummeted by 85.41% to $141544.0 in 2022, then plummeted by 32.75% to $95182.0 in 2023, then crashed by 83.37% to $15832.0 in 2024, then surged by 440.57% to $85583.0 in 2025.
  • The last three reported values for Treasury Shares were $85583.0 (Q4 2025), $15832.0 (Q4 2024), and $95182.0 (Q4 2023) per Business Quant data.